Paper512
The refined crystal structure of bovine beta-trypsin at 1.8 A resolution. II. Crystallographic refinement, calcium binding site, benzamidine binding site and active site at pH 7.0.
Bode W and 1 other. J Mol Biol, 1975. Cited by 435 papers, by iCite.
Cite this record
ConductScience Library. The refined crystal structure of bovine beta-trypsin at 1.8 A resolution. II. Crystallographic refinement, calcium binding site, benzamidine binding site and active site at pH 7.0. Papers, record 512. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/512
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- The refined crystal structure of bovine beta-trypsin at 1.8 A resolution. II. Crystallographic refinement, calcium binding site, benzamidine binding site and active site at pH 7.0.
- PubMed
Topics15
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Trypsin | Major topic |
| Amino Acid Sequence | |
| Animals | |
| Benzamidines | |
| Binding Sites | |
| Calcium | |
| Cattle | |
| Crystallization | |
| Fourier Analysis | |
| Hydrogen-Ion Concentration | |
| Mathematics | |
| Models, Molecular | |
| Protein Binding | |
| Protein Conformation | |
| Water |
Source PubMed
Cited by64
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 435 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 40347331 | Zymography: Unveiling Matrix Metalloproteinase Dynamics. | Methods Mol Biol | 2025 | https://conductscience.org/library/papers/40347331 | PubMed |
| 39122806 | The early communication stages between serine proteases and enterovirus capsids in the race for viral disintegration. | Commun Biol | 2024 | https://conductscience.org/library/papers/39122806 | PubMed |
| 38325732 | Optimal conditions for carrying out trypsin digestions on complex proteomes: From bulk samples to single cells. | J Proteomics | 2024 | https://conductscience.org/library/papers/38325732 | PubMed |
| 35260627 | A systematic approach for evaluating the role of surface-exposed loops in trypsin-like serine proteases applied to the 170 loop in coagulation factor VIIa. | Sci Rep | 2022 | https://conductscience.org/library/papers/35260627 | PubMed |
| 33673063 | Effect of Concentrated Salts Solutions on the Stability of Immobilized Enzymes: Influence of Inactivation Conditions and Immobilization Protocol. | Molecules | 2021 | https://conductscience.org/library/papers/33673063 | PubMed |
| 32201777 | Kinetic Studies of the Effect of pH on the Trypsin-Catalyzed Hydrolysis of N-α-benzyloxycarbonyl-l-lysine-p-nitroanilide: Mechanism of Trypsin Catalysis. | ACS Omega | 2020 | https://conductscience.org/library/papers/32201777 | PubMed |
| 31537874 | Fragment-based discovery of the first nonpeptidyl inhibitor of an S46 family peptidase. | Sci Rep | 2019 | https://conductscience.org/library/papers/31537874 | PubMed |
| 30394658 | Factor XII truncation accelerates activation in solution. | J Thromb Haemost | 2019 | https://conductscience.org/library/papers/30394658 | PubMed |
| 30322187 | Pseudotrypsin: A Little-Known Trypsin Proteoform. | Molecules | 2018 | https://conductscience.org/library/papers/30322187 | PubMed |
| 29519898 | Structures of human plasma β-factor XIIa cocrystallized with potent inhibitors. | Blood Adv | 2018 | https://conductscience.org/library/papers/29519898 | PubMed |
| 26057589 | Structural and mutational analyses of dipeptidyl peptidase 11 from Porphyromonas gingivalis reveal the molecular basis for strict substrate specificity. | Sci Rep | 2015 | https://conductscience.org/library/papers/26057589 | PubMed |
| 24827749 | S46 peptidases are the first exopeptidases to be members of clan PA. | Sci Rep | 2014 | https://conductscience.org/library/papers/24827749 | PubMed |
| 24676141 | Trypsin- and Chymotrypsin-like serine proteases in schistosoma mansoni-- 'the undiscovered country'. | PLoS Negl Trop Dis | 2014 | https://conductscience.org/library/papers/24676141 | PubMed |
| 24507592 | Biophysical highlights from 54 years of macromolecular crystallography. | Biophys J | 2014 | https://conductscience.org/library/papers/24507592 | PubMed |
| 23430773 | Use of (113)Cd NMR to probe the native metal binding sites in metalloproteins: an overview. | Met Ions Life Sci | 2013 | https://conductscience.org/library/papers/23430773 | PubMed |
| 21778227 | The role of factor XIa (FXIa) catalytic domain exosite residues in substrate catalysis and inhibition by the Kunitz protease inhibitor domain of protease nexin 2. | J Biol Chem | 2011 | https://conductscience.org/library/papers/21778227 | PubMed |
| 20423310 | Regulation of the protein C anticoagulant and antiinflammatory pathways. | Curr Med Chem | 2010 | https://conductscience.org/library/papers/20423310 | PubMed |
| 19640005 | Mutagenesis studies toward understanding allostery in thrombin. | Biochemistry | 2009 | https://conductscience.org/library/papers/19640005 | PubMed |
| 17848548 | Restricted active site docking by enzyme-bound substrate enforces the ordered cleavage of prothrombin by prothrombinase. | J Biol Chem | 2007 | https://conductscience.org/library/papers/17848548 | PubMed |
| 16770643 | Study of the inhibition of cyclin-dependent kinases with roscovitine and indirubin-3'-oxime from molecular dynamics simulations. | J Mol Model | 2007 | https://conductscience.org/library/papers/16770643 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/512
GET https://conductscience.org/api/papers/v1/512/cited_by?page=2